Approvals/TGA/Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe

Approved

STANDARD

Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4edad4ff7b0843af
Product Name: Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe
Artg Id: 427956
Artg Name: Tezspire, tezepelumab 210 mg in 1.91mL solution for Injection prefilled syringe
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2025-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2f57df40534991738662a2c8feb68c4e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9d3e37730b6d967e30d71f359485fa96.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

4edad4ff7b0843af

Type

Standard